Command Palette

Search for a command to run...

All algorithms

Incidental Liver Lesion (CT)

Walk the decision tree step by step, see it as a flowchart, or view the whole algorithm at once.
ACR IFC 2017·reviewed 2026-10-01
  • •Low risk (Table 1): no known malignancy, no hepatic dysfunction, no hepatic risk factors. Within this group, patients >40 years are at higher risk than younger ones. High risk: known malignancy with a propensity to metastasize to the liver, cirrhosis, or other hepatic risk factors — hepatitis, alcoholism, NASH, sclerosing cholangitis, primary biliary cirrhosis, choledochal cysts, hemochromatosis and other hereditary liver conditions, anabolic steroid use.
  • •Benign features: sharp margin, homogeneous low attenuation (≤20 HU) on unenhanced and/or portal venous–phase CT, or the characteristic features of hemangioma, FNH, focal fatty sparing or deposition, or perfusional change. With pseudoenhancement a benign cyst may measure >20 HU; use judgment.
  • •Suspicious features: ill-defined margins, heterogeneous density, mural thickening or nodularity, thick septa, or intermediate-to-high attenuation (>20 HU) on portal venous–phase imaging without pseudoenhancement. With pre- and postcontrast CT, enhancement >20 HU is suspicious. Prefer MRI to evaluate.
  • •'Flash-filling': uniform hyperenhancement relative to liver on arterial-phase (including late arterial/early portal venous) imaging. If other phases show the lesion is benign (e.g., hemangioma) or suspicious (e.g., HCC), use those categories instead.
  • •If the available imaging cannot separate benign from suspicious features in a lesion ≥1 cm, recommend prompt MRI.
  • •Differentiating FNH from adenoma matters, especially for lesions >3 cm and subcapsular; use MRI with gadoxetate disodium. If biopsy is done, core biopsy is preferred over fine-needle aspiration.
  • •This algorithm is for incidental lesions. For a cirrhotic patient in HCC surveillance, use LI-RADS.

Size of the liver lesion?

Tip: press 1–3 to choose, Backspace to go back.

Sources

  • Gore RM, et al. Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017;14(11):1429-1437.

Educational reference for clinicians — not medical advice. Verify against the primary source before acting on it; guidelines change. Final decisions rest with the interpreting physician and your institution's protocols.